Understanding the pharmacology of COVID-19 mRNA vaccines: playing dice with the spike?
M Cosentino, F Marino - International journal of molecular sciences, 2022 - mdpi.com
Coronavirus disease-19 (COVID-19) mRNA vaccines are the mainstays of mass vaccination
campaigns in most Western countries. However, the emergency conditions in which their …
campaigns in most Western countries. However, the emergency conditions in which their …
The impact of early therapies for COVID-19 on death, hospitalization and persisting symptoms: a retrospective study
P Bertuccio, M Degli Antoni, D Minisci, S Amadasi… - Infection, 2023 - Springer
Purpose Oral antivirals (nirmatrelvir/ritonavir and molnupiravir), intravenous short treatment
of remdesivir and anti-SARS-CoV-2 monoclonal antibodies (mAbs) have been used for early …
of remdesivir and anti-SARS-CoV-2 monoclonal antibodies (mAbs) have been used for early …
AC-73 and Syrosingopine Inhibit SARS-CoV-2 Entry into Megakaryocytes by Targeting CD147 and MCT4
I Spinello, E Saulle, MT Quaranta, E Pelosi, G Castelli… - Viruses, 2024 - mdpi.com
Coagulation disorders are described in COVID-19 and long COVID patients. In particular,
SARS-CoV-2 infection in megakaryocytes, which are precursors of platelets involved in …
SARS-CoV-2 infection in megakaryocytes, which are precursors of platelets involved in …
Case report: A case of Acute Macular Neuroretinopathy secondary to Influenza A virus during Long COVID
J Zhang, Y Xia, X Li, R He, X Xie - Frontiers in Immunology, 2024 - frontiersin.org
Ocular abnormalities have been reported in association with viral infections, including Long
COVID, a debilitating illness caused by the Severe Acute Respiratory Syndrome …
COVID, a debilitating illness caused by the Severe Acute Respiratory Syndrome …